Cargando…
Discordance between testosterone measurement methods in castrated prostate cancer patients
Failure to suppress testosterone below 0.7 nM in castrated prostate cancer patients is associated with poor clinical outcomes. Testosterone levels in castrated patients are therefore routinely measured. Although mass spectrometry is the gold standard used to measure testosterone, most hospitals use...
Autores principales: | Rouleau, Mélanie, Lemire, Francis, Déry, Michel, Thériault, Benoît, Dubois, Gabriel, Fradet, Yves, Toren, Paul, Guillemette, Chantal, Lacombe, Louis, Klotz, Laurence, Saad, Fred, Guérette, Dominique, Pouliot, Frédéric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376995/ https://www.ncbi.nlm.nih.gov/pubmed/30673630 http://dx.doi.org/10.1530/EC-18-0476 |
Ejemplares similares
-
Follicle-stimulating hormone (FSH) levels prior to prostatectomy are not related to long-term oncologic or cardiovascular outcomes for men with prostate cancer
por: Kourbanhoussen, Kassim, et al.
Publicado: (2021) -
Effects of omega‐3 supplementation on psychological symptoms in men with prostate cancer: Secondary analysis of a double‐blind placebo‐controlled randomized trial
por: Savard, Josée, et al.
Publicado: (2023) -
Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer
por: Rouleau, Michèle, et al.
Publicado: (2022) -
High infiltration of CD209(+) dendritic cells and CD163(+) macrophages in the peritumor area of prostate cancer is predictive of late adverse outcomes
por: Molina, Oscar Eduardo, et al.
Publicado: (2023) -
Subversion of infiltrating prostate macrophages to a mixed immunosuppressive tumor‐associated macrophage phenotype
por: Boibessot, Clovis, et al.
Publicado: (2022)